Project
A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of BG00012 monotherapy with Relapsin Remitting Multiple Sclerosis
Automatically Closed · 2010 until 2020
Müller Stefanie, Vehoff Jochen
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2010
End Date
2020
Financing
Industry
Brief description/objective
A dose blind, multicenter, extension study to determine the safety and efficasy of 2 doses of dimethyl fumarate (BG00012) monotherapy with Relapsin Remitting Multiple Sclerosis